ACADIA Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This assessment of ACADIA Pharmaceuticals Inc employs data from across the web and also from public filings by ACADIA Pharmaceuticals Inc. This ESG assessment for ACADIA Pharmaceuticals Inc represents its reporting of the UN Sustainable Development Goals. This ESG rating includes seventeen United Nations SDGs including: 'Gender Equality', 'Sustainable Cities & Communities' and 'Life on Land'.
ACADIA Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | ACADIA Pharmaceuticals Inc | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does ACADIA Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Does ACADIA Pharmaceuticals Inc disclose current and historical energy intensity?
Does ACADIA Pharmaceuticals Inc report the average age of the workforce?
Does ACADIA Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Does ACADIA Pharmaceuticals Inc disclose its ethnicity pay gap?
Does ACADIA Pharmaceuticals Inc disclose cybersecurity risks?
Does ACADIA Pharmaceuticals Inc offer flexible work?
Does ACADIA Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does ACADIA Pharmaceuticals Inc disclose the number of employees in R&D functions?
Does ACADIA Pharmaceuticals Inc conduct supply chain audits?
Does ACADIA Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does ACADIA Pharmaceuticals Inc conduct 360 degree staff reviews?
Does ACADIA Pharmaceuticals Inc disclose the individual responsible for D&I?
Does ACADIA Pharmaceuticals Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does ACADIA Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Does ACADIA Pharmaceuticals Inc disclose water use targets?
Does ACADIA Pharmaceuticals Inc have careers partnerships with academic institutions?
Did ACADIA Pharmaceuticals Inc have a product recall in the last two years?
Does ACADIA Pharmaceuticals Inc disclose incidents of discrimination?
Does ACADIA Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Has ACADIA Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does ACADIA Pharmaceuticals Inc disclose parental leave metrics?
Does ACADIA Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does ACADIA Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does ACADIA Pharmaceuticals Inc disclose the pay ratio of women to men?
Does ACADIA Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does ACADIA Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does ACADIA Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is ACADIA Pharmaceuticals Inc involved in embryonic stem cell research?
Does ACADIA Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Does ACADIA Pharmaceuticals Inc disclose its waste policy?
Does ACADIA Pharmaceuticals Inc report according to TCFD requirements?
Does ACADIA Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does ACADIA Pharmaceuticals Inc disclose energy use targets?
Does ACADIA Pharmaceuticals Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does ACADIA Pharmaceuticals Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for ACADIA Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.